Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Bristol-Myers: A $44 Billion High-Yield Stock That Could Be in Trouble
Bristol-Myers: A $44 Billion High-Yield Stock That Could Be in Trouble
Bristol-Myers: A $44 Billion High-Yield Stock That Could Be in Trouble
Submitted by
admin
on March 24, 2011 - 9:19am
Source:
Seeking Alpha
News Tags:
Bristol-Myers Squibb
Headline:
Bristol-Myers: A $44 Billion High-Yield Stock That Could Be in Trouble
Do Not Allow Advertisers to Use My Personal information
